Worth reading
57In focus
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
1594
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPNet Sales11,996¥ millionYear on year +22.3%Progress 76.9%
Operating profit1,594¥ millionProgress 69.3%
Ordinary income1,566¥ million
Net income attributable to owners of the parent1,533¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥18.13
Operating Margin13.3％
Financial position at period-end
Total assets9,436¥ million
of which net assets 4,750 ¥ millionEquity ratio 48.1%vs. prior year-end +13.8pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+1,725
Investment-1,040
Financials+285
Net change+970
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥3,979 million
Segment revenueAI Product Business ¥4,916 million (YoY +60.9%), AI Solution Services Business ¥7,238 million (YoY +2.7%)
Segment profitAI Product Business ¥1,866 million (YoY +147.9%), AI Solution Services Business ¥2,217 million (YoY +58.7%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥15,600 million (YoY +30.0%)
Operating profit¥2,300 million (YoY +44.3%)
Ordinary incomeNot disclosed
Net incomeNot disclosed
Annual Dividend Forecast¥0 → ¥5
Factors Behind Changes in Business Performance
Increased service usage in the AI Product Business, strong demand for generative AI and AI agents, higher operating productivity following a review of AI development projects, controls on personnel expenses and outsourcing costs, and lower depreciation and amortization expenses due to impairment losses recorded in the previous fiscal year.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Material subsequent eventsThe HR Tech Business was transferred through an absorption-type company split to a wholly owned subsidiary, with the transfer completed on 1 April 2026. 株式会社Exa Frontier Edge was established on 1 April 2026. Additional shares in 株式会社エクサホームケア were acquired on 30 April 2026, making it a wholly owned subsidiary. On 12 May 2026, the company resolved to merge エクサホームケア into ExaMD through an absorption-type merger and to transfer the company's CareWizタクスト and CareWiz BCP businesses to ExaMD through an absorption-type company split. These transactions are scheduled to be completed on 1 July 2026. The additional information also describes a capital and business alliance with the SMBC Group and a third-party allotment of shares.
Impairment loss¥22 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥2 million, Other ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥0 million, Impairment Losses ¥22 million
Depreciation and amortization¥324 million
Availability of Financial Results BriefingHeld (対象者：Not disclosed)
Issued Shares at Period-End87,156,500
Treasury Shares at Period-End1,774,813
Supplementary financial results materialsYes
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥11,996 million (YoY +22.3%) |
| Operating profit | ¥1,594 million |
| Ordinary income | ¥1,566 million |
| Profit attributable to owners of the parent | ¥1,533 million |
| Net income per share | ¥18.13 |
| Operating Margin | 13.3％ |
| Equity ratio | End of the current fiscal period 48.1％ / End of previous period 34.3％ |
| Total assets | ¥9,436 million |
| Net assets | ¥4,750 million |
| Cash flows from operating activities | ¥1,725 million |
| Cash flows from investing activities | ¥-1,040 million |
| Cash flows from financing activities | ¥285 million |
| Cash and cash equivalents at end of period | ¥3,979 million |
| Full-year earnings forecast | Net Sales ¥15,600 million (YoY +30.0%) / Operating profit ¥2,300 million (YoY +44.3%) / Ordinary income Not disclosed / Net income Not disclosed |
| Annual Dividend Forecast | ¥0 → ¥5 |
| Segment revenue | AI Product Business ¥4,916 million (YoY +60.9%), AI Solution Services Business ¥7,238 million (YoY +2.7%) |
| Segment profit | AI Product Business ¥1,866 million (YoY +147.9%), AI Solution Services Business ¥2,217 million (YoY +58.7%) |
| Depreciation and amortization | ¥324 million |
| Impairment loss | ¥22 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥2 million, Other ¥0 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥0 million, Impairment Losses ¥22 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | The HR Tech Business was transferred through an absorption-type company split to a wholly owned subsidiary, with the transfer completed on 1 April 2026. 株式会社Exa Frontier Edge was established on 1 April 2026. Additional shares in 株式会社エクサホームケア were acquired on 30 April 2026, making it a wholly owned subsidiary. On 12 May 2026, the company resolved to merge エクサホームケア into ExaMD through an absorption-type merger and to transfer the company's CareWizタクスト and CareWiz BCP businesses to ExaMD through an absorption-type company split. These transactions are scheduled to be completed on 1 July 2026. The additional information also describes a capital and business alliance with the SMBC Group and a third-party allotment of shares. |
| Supplementary financial results materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 87,156,500 |
| Treasury Shares at Period-End | 1,774,813 |
| Factors Behind Changes in Business Performance | Increased service usage in the AI Product Business, strong demand for generative AI and AI agents, higher operating productivity following a review of AI development projects, controls on personnel expenses and outsourcing costs, and lower depreciation and amortization expenses due to impairment losses recorded in the previous fiscal year. |
Items this document does not state (5)
Revision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited increased service usage in the AI Product Business, growing demand for AI, higher operating productivity following a review of AI development projects, controls on personnel expenses and outsourcing costs, and lower depreciation and amortization expenses due to a decrease in impairment losses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.